Polynesian Wound-Healing Oil with a Unique Anti-Inflammatory Compound

How a green-gold oil pressed from Calophyllum inophyllum nuts heals wounds, calms inflamed skin, and inhibits acne bacteria — and what its key compound calophyllolide actually does in human and animal studies

Tamanu oil is a thick, green-gold oil cold-pressed from the nuts of Calophyllum inophyllum, a coastal tree native to Polynesia, Southeast Asia, and the Indian Ocean. For centuries, Pacific Islander cultures have applied it directly to burns, cuts, scars, infected wounds, eczema, and rashes [1]. Modern research backs up much of that traditional use: the oil contains a unique compound called calophyllolide that controls inflammation in healing skin, accelerates wound closure, and inhibits the bacteria responsible for acne and infected wounds [3]. Unlike most plant oils, tamanu is not just a passive moisturizer — it is genuinely bioactive on skin [2].

What Tamanu Oil Is and How It Works

Tamanu oil is pressed from the dried kernels of mature Calophyllum inophyllum nuts. Authentic Polynesian-style tamanu undergoes a slow drying step (typically 4–8 weeks of sun-curing) that allows the oil yield to triple and the bioactive compound profile to develop fully [1]. The finished oil is dark green to greenish-gold, has a distinct nutty-spicy aroma, and is unusually viscous compared to oils like jojoba or rosehip.

The oil contains two functional layers:

A fatty-acid base of oleic acid (about 30–40%), linoleic acid (about 30%), palmitic acid (about 12%), and stearic acid (about 14%). This base provides emollient and barrier-supporting effects similar to other plant oils.
A neoflavonoid and triterpene fraction that is the source of tamanu's distinctive activity. The dominant active compound is calophyllolide, a pyranocoumarin-type neoflavonoid first identified as a non-steroidal anti-inflammatory agent [3]. Other neoflavonoids (inophyllum P, calanolides) and the resinous fraction contribute additional antibacterial and antioxidant activity.

This bioactive fraction is what differentiates tamanu from most cosmetic oils. In a Polynesian study on cultured human skin cells, tamanu oil emulsion increased keratinocyte and fibroblast proliferation, stimulated collagen production, accelerated in vitro wound closure, and triggered gene expression changes in pathways involved in cell adhesion, glycan biosynthesis, and proliferation — effects that simple fatty-acid carrier oils do not reproduce [2].

What It Helps With

Wound healing. This is tamanu's strongest evidence base. In vivo rat studies have shown that topical tamanu oil applied to standardized cutaneous wounds significantly accelerates closure and improves the histology of healing tissue compared to vehicle controls [5]. In a mechanistic mouse study, the isolated calophyllolide compound reduced systemic pro-inflammatory cytokines (IL-1β by ~87%, IL-6 by ~74%, TNF-α by ~70% at day 5) while increasing the anti-inflammatory cytokine IL-10 — and shifted wound macrophages from the destructive M1 phenotype toward the constructive M2 phenotype that resolves inflammation and rebuilds tissue [3].

Inflamed and infected skin. Five different ethno-medical tamanu oils tested in vitro showed direct inhibition of Gram-positive bacteria including Staphylococcus aureus, plus indirect activity against Gram-negative bacteria via macrophage release of the antimicrobial peptide β-defensin-2 [1]. This dual mechanism — direct antibacterial action plus immune-system priming — is unusual among plant oils.

Acne. The neoflavonoid fraction has been shown to inhibit Cutibacterium acnes (formerly Propionibacterium acnes), the bacterium central to inflammatory acne. The combination of antibacterial activity, anti-inflammatory cytokine modulation, and the oil's surprisingly low comedogenic profile makes it a popular addition to acne-prone skincare formulations.

Eczema and atopic dermatitis. Atopic dermatitis is driven by inflammation, oxidative stress, microbial imbalance, and skin barrier disruption — and tamanu oil acts on all four [4]. A 2021 review concluded that tamanu's combined anti-inflammatory, antioxidant, antimicrobial, and barrier-supporting effects make it a plausible candidate for atopic dermatitis management, though formal human clinical trials in atopic dermatitis are still limited.

Scars and stretch marks. The combination of fibroblast stimulation, collagen production, and anti-inflammatory cytokine modulation is mechanistically aligned with scar maturation and remodeling. Traditional Polynesian use for scar fading is well documented, and modern formulation work (anti-scarring bigels) is in early development.

How to Use It

Application. Use a few drops as a leave-on serum at night, or spot-apply to wounds, blemishes, irritated areas, or scars. Tamanu oil is heavy and slow-absorbing — it is generally better used at night, blended into a lighter carrier (jojoba, squalane), or under a moisturizer rather than as a primary daytime moisturizer.

Sourcing. Look for cold-pressed, unrefined Polynesian or Vanuatu-origin tamanu — the dark green color and characteristic smell indicate the bioactive fraction is intact. Pale yellow or odorless "tamanu oil" has typically been bleached or refined and likely lost much of its calophyllolide content. Authentic oil is shelf-stable for 1–2 years if kept cool and dark.

Patch test first. Tamanu has a documented (though uncommon) risk of allergic contact dermatitis, especially in people sensitized to other tropical plants of the Calophyllum genus or to balsam-of-Peru-type fragrance allergens [6]. Apply a small amount to the inner forearm for 48 hours before broader use.

Tree nut allergy. Although the calophyllolide fraction is the main active and the oil is mostly triglycerides, anyone with a known tree-nut allergy should check with their clinician before topical use.

On open wounds. Traditional Polynesian use applies tamanu directly to open wounds, and the antibacterial evidence supports this practice. Modern guidance is more conservative: clean a wound first, and if it is deep, on the face, or shows signs of infection, see a clinician rather than self-treating.

Cross-reference: see our Jojoba Oil page for a lighter carrier oil to dilute tamanu in, our Castor Oil page for another traditional wound-care oil with anti-inflammatory ricinoleic acid, and our Bakuchiol page for a complementary anti-aging active that pairs well with tamanu in nighttime routines.

Evidence Review

Léguillier et al., 2015 (PLoS One) — wound healing and antibacterial activity of five tamanu oils [1]. This is the foundational modern study of authentic, traditionally-prepared tamanu oils. Researchers obtained five oils from Indonesia, Tahiti, Fiji, and New Caledonia, characterized their fatty acid and resinous fractions, and tested cytotoxicity, in vitro wound healing in human keratinocytes, and antibacterial activity against eight reference strains. All five oils were non-toxic to human keratinocytes at therapeutic concentrations. All five accelerated in vitro wound closure compared to controls. Antibacterial testing showed direct inhibition of Gram-positive bacteria (S. aureus, Enterococcus faecalis, others) with MIC values comparable to standard antibiotics for some strains, plus indirect activity against Gram-negative bacteria mediated by macrophage release of β-defensin-2. The strength of this study lies in testing multiple traditionally prepared oils side by side and confirming that the antibacterial effect is partly immune-mediated (not just direct chemical kill), which helps explain why traditional preparations have been effective on infected wounds for centuries.

Ansel et al., 2016 (Planta Medica) — biological activity on human skin cells [2]. A French Polynesian research team formulated a tamanu oil emulsion and tested it on cultured human keratinocytes (HaCaT cells) and dermal fibroblasts. The emulsion stimulated cell proliferation in both cell types, increased glycosaminoglycan and collagen production, and accelerated scratch-wound closure. Transcriptomic analysis (gene expression profiling) showed modulation of genes involved in O-glycan biosynthesis, cell adhesion, and proliferation pathways. The authors attributed these effects to neoflavonoids, particularly calophyllolide. This is one of the only human-cell studies that demonstrates tamanu acts at the gene-expression level, not just as a passive moisturizer.

Nguyen et al., 2017 (PLoS One) — calophyllolide mechanism in mouse wounds [3]. This is the most mechanistically detailed study of tamanu's main active compound. Researchers isolated calophyllolide (CP) from C. inophyllum and applied it to standardized cutaneous wounds in mice, with detailed cytokine and macrophage-phenotype tracking. CP downregulated systemic pro-inflammatory cytokines: IL-1β by 83.7 pg/mL (87%) at day 5 and 8.7 pg/mL (75%) at day 7; IL-6 by 38.5 pg/mL (74%) at day 5 and 16.6 pg/mL (80%) at day 7; TNF-α by 2.1 pg/mL (70%) at day 5 and 2.2 pg/mL (90%) at day 7 versus vehicle. Anti-inflammatory IL-10 was upregulated. CP also shifted macrophage phenotype from the inflammatory M1 (CD14, CD127 down 1.2–4.3 fold) to the reparative M2 (CD163 up 4.5–8.4 fold; CD206 up 2.9–5.7 fold). Wound closure was significantly accelerated. This study is important because it identifies the molecular target of tamanu's wound-healing activity — controlled cytokine modulation and macrophage polarization toward resolution — and explains why tamanu doesn't merely suppress inflammation but actively promotes healing.

Erdogan et al., 2021 (Journal of Wound Care) — rat wound healing study [5]. A Turkish dermatology research group induced standardized full-thickness cutaneous wounds in rats and randomized animals to topical tamanu oil, a reference healing drug, or vehicle. Wound contraction, histological assessment of macrophage and granulation tissue formation, and fibrosis quality were measured over 21 days. Tamanu oil accelerated formation of macrophage-granulation tissue-fibrosis with less wound contraction than the reference drug — meaning the wounds healed by genuine tissue regeneration rather than by simple contracture. This is clinically relevant because contracture-based healing leaves tighter, more functionally limited scars, while granulation-based healing produces more elastic, normal-appearing tissue.

Pribowo et al., 2021 (eCAM) — atopic dermatitis review [4]. A 2021 review synthesized the in vitro and animal evidence on tamanu oil's relevance to atopic dermatitis pathophysiology. The authors mapped tamanu's documented properties (anti-inflammatory, antioxidant, antimicrobial, wound-healing, barrier-supporting) onto the four main drivers of atopic dermatitis: chronic inflammation (especially IL-4, IL-13, IL-31 cytokine signaling), oxidative stress, Staphylococcus aureus colonization, and skin barrier dysfunction. They concluded tamanu is a strong candidate for adjunctive atopic dermatitis treatment but explicitly noted that no formal randomized human trials in atopic dermatitis exist yet. This review is the best summary of the mechanistic case but should not be cited as evidence of clinical efficacy.

Le Coz, 2004 (Contact Dermatitis) — allergic contact dermatitis case report [6]. An important counterweight to the enthusiasm: a French dermatologist documented a clear case of allergic contact dermatitis from topical tamanu oil. The patient had cross-reactivity to other Calophyllum species (C. tacamahaca) and to balsam-related compounds, suggesting a fragrance/resin sensitization pattern. The base rate of this reaction appears low (it is not a commonly reported sensitizer), but it is non-zero. Patch testing before broad facial or repeated use is the appropriate practical response.

Strengths and limitations of the overall evidence base. Tamanu oil has unusually strong in vitro and animal evidence for its claimed effects, including a well-characterized active compound (calophyllolide) with a defined mechanism of action. The cytokine modulation, macrophage polarization, and antimicrobial data are reproduced across independent labs and species. What is genuinely missing is human randomized controlled trials. There are no large dermatology-quality RCTs of tamanu oil for any specific condition (acne, atopic dermatitis, scars, wound healing). Confidence in tamanu for general topical use as a natural healing oil is reasonably high based on convergent mechanistic evidence and centuries of traditional use; confidence in it as a treatment for any specific medical condition should remain conservative pending human trials. For day-to-day use on minor cuts, scrapes, blemishes, dry patches, scars, and inflamed skin, the existing evidence is more than sufficient. For chronic or severe skin disease, it should complement rather than replace evidence-based dermatologic care.

References

The Wound Healing and Antibacterial Activity of Five Ethnomedical Calophyllum inophyllum Oils: An Alternative Therapeutic Strategy to Treat Infected WoundsLéguillier T, Lecsö-Bornet M, Lémus C, Rousseau-Ralliard D, Lebouvier N, Hnawia E, Nour M, Aalbersberg W, Ghazi K, Raharivelomanana P, Rat P. PLoS One, 2015. PubMed 26406588 →
Biological Activity of Polynesian Calophyllum inophyllum Oil Extract on Human Skin CellsAnsel JL, Lupo E, Mijouin L, Guillot S, Butaud JF, Ho R, Lecellier G, Raharivelomanana P, Pichon C. Planta Medica, 2016. PubMed 27280931 →
Anti-inflammatory and wound healing activities of calophyllolide isolated from Calophyllum inophyllum LinnNguyen VL, Truong CT, Nguyen BCQ, Vo TV, Dao TT, Nguyen VD, Trinh DT, Huynh HK, Bui CB. PLoS One, 2017. PubMed 29020015 →
Potential of Tamanu (Calophyllum inophyllum) Oil for Atopic Dermatitis TreatmentPribowo A, Girish J, Gustiananda M, Nandhira RG, Hartrianti P. Evidence-Based Complementary and Alternative Medicine, 2021. PubMed 35069754 →
Evaluation of the cutaneous wound healing potential of tamanu oil in wounds induced in ratsErdogan SS, Gur TF, Terzi NK, Dogan B. Journal of Wound Care, 2021. PubMed 34597168 →
Allergic contact dermatitis from tamanu oil (Calophyllum inophyllum, Calophyllum tacamahaca)Le Coz CJ. Contact Dermatitis, 2004. PubMed 15500678 →